Showing results (341-350 of 425) with videos related to
Sort By:
Pageof 43
Annals of Surgical Oncology|May 25, 2012
Biology, treatment, and outcome in very young and older women with DCISRosalinda Alvarado, Sara A Lari, Robert E Roses, et al.NPJ Breast Cancer|November 9, 2019
If we build it they will come: targeting the immune response to breast cancerMargaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, et al.Journal for Immunotherapy of Cancer|February 26, 2025
Phase I study of ribociclib (CDK4/6 inhibitor) with spartalizumab (PD-1 inhibitor) with and without fulvestrant in metastatic hormone receptor-positive breast cancer or advanced ovarian cancerAna C Garrido-Castro, Noah Graham, Lestat R Ali, et al.Expert Opinion on Biological Therapy|September 8, 2011
AE37: a novel T-cell-eliciting vaccine for breast cancerAlan K Sears, Sonia A Perez, Guy T Clifton, et al.Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 13, 2012
The role of antigen cross-presentation from leukemia blasts on immunity to the leukemia-associated antigen PR1Gheath Alatrash, Yoko Ono, Anna Sergeeva, et al.Frontiers in Immunology|February 10, 2018
Cathepsin G Is Expressed by Acute Lymphoblastic Leukemia and Is a Potential Immunotherapeutic TargetMaliha Khan, Selena Carmona, Pariya Sukhumalchandra, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 21, 2025
Association of tumor-infiltrating lymphocyte subtypes with clinical characteristics and prognosis in young women with hormone receptor-positive breast cancerMegan E Tesch, Yue Zheng, Yaileen D Guzman-Arocho, et al.NPJ Breast Cancer|February 13, 2026
Androgen receptor expression and immune characteristics of HER2-low metastatic triple-negative breast cancerPaolo Tarantino, Jaeyoon Cha, Busem Binboga Kurt, et al.Annals of Surgical Oncology|July 14, 2016
Operative and Oncologic Outcomes in 9861 Patients with Operable Breast Cancer: Single-Institution Analysis of Breast Conservation with Oncoplastic ReconstructionStacey A Carter, Genevieve R Lyons, Henry M Kuerer, et al.Nature Communications|November 29, 2025
Cellular reprogramming during anti-PD-1 and chemotherapy treatment in early-stage primary hormone receptor-positive breast cancerJingxin Fu, Adrienne G Waks, Erica Pimenta, et al.Pageof 43